The Role of Melatonin in Insomnia and Neurodegenerative Conditions: A Critical Study

Komal Parashar, Ashutosh Niranjan, Naresh Kaushik, Suvendu Narayan Mishra, Lokesh Ravilla and Madhur Grover

Seminars in Medical Writing and Education, 2025, vol. 4, 461

Abstract: The subsequent leading cause of mortality, neurodegenerative diseases (ND), gradually reduces the capacity of the central or peripheral nervous system to function properly and think coherently. In contemporary culture, the primary goal of public health is ND prevention. Numerous physiological functions in the brain are regulated by the hormone Melatonin (MLT), It was generated in the Pineal Gland (PG). Circadian rhythms (CR), biomolecular oxidation, eliminating free radicals, and preventing neuroinflammation are some of these mechanisms. MLT has been proven to have a multitude of neuroprotective effects through altering signaling pathways and pathophysiological processes. Neurological disorders may cause lower MLT levels. MLT regulates itself, interacts with molecules, and affects biological processes in ND. We also discuss the therapeutic use of MLT in the management of neurodegenerative illnesses. This knowledge might lead to the development of cutting-edge therapeutic approaches for the treatment of different ND and further our understanding of how MLT controls the brain's Circadian Rhythm (CR).

Date: 2025
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:medicw:v:4:y:2025:i::p:461:id:461

DOI: 10.56294/mw2025461

Access Statistics for this article

More articles in Seminars in Medical Writing and Education from AG Editor (Argentina)
Bibliographic data for series maintained by Javier Gonzalez-Argote ().